User Requirements
I require codelists for diabetes medications. These are required so that I can generate appropriate aggregate data for external collaborators who are interested in the impact of GLP-1s being prescribed for weight loss given the limited supply of these drugs.
I am unable to create a codelist myself as I do not know about medications.
Here is what has been requested:
Relevant products
• GLP-1s (only)
• insulin (only)
• GLP-1 + insulin (Basal) co prescribing
• GLP-1 + insulin (non Basal) co prescribing
• GLP-1 + insulins combination product
• Neither GLP - 1 nor insulin (dpp4_ inhibitors, metformin, pioglitazone, sglt_2_inhibitors, sulfonylureas, other medication, no medication).
To obtain the variable GLP-1 + insulin (Basal) co prescribing I will require a GLP-1 codelist and a insulin (Basal) codelist and then I can do the logical combination of the variables in my data definition.
For GLP-1 + insulin combination product, I thought this was 1 single medication, however I am now aware that combination insulin products exist and therefore this could mean GLP-1 + (combined insulin) co-prescribing, but I am unsure. Clinical advice would be appreciated. I am happy to email the externals and ask, but ideally I would like to propose a sensible interpretation of what they have written so require help from a clinical informatician.
User Requirements I require codelists for diabetes medications. These are required so that I can generate appropriate aggregate data for external collaborators who are interested in the impact of GLP-1s being prescribed for weight loss given the limited supply of these drugs.
I am unable to create a codelist myself as I do not know about medications.
Here is what has been requested: Relevant products • GLP-1s (only) • insulin (only) • GLP-1 + insulin (Basal) co prescribing • GLP-1 + insulin (non Basal) co prescribing • GLP-1 + insulins combination product • Neither GLP - 1 nor insulin (dpp4_ inhibitors, metformin, pioglitazone, sglt_2_inhibitors, sulfonylureas, other medication, no medication).
To obtain the variable GLP-1 + insulin (Basal) co prescribing I will require a GLP-1 codelist and a insulin (Basal) codelist and then I can do the logical combination of the variables in my data definition.
For GLP-1 + insulin combination product, I thought this was 1 single medication, however I am now aware that combination insulin products exist and therefore this could mean GLP-1 + (combined insulin) co-prescribing, but I am unsure. Clinical advice would be appreciated. I am happy to email the externals and ask, but ideally I would like to propose a sensible interpretation of what they have written so require help from a clinical informatician.
This issue is related to this request.
Some codelists already exist for this project; what I (think I) specifically need help with is the insulin codelists and the GLP-1 codelists.
insulin (which needs to be separated into multiple codelists?) user/alex-walker/insulin-dmd/09cced29/
GLP-1s (that need to be separated, as per other issue?) https://www.opencodelists.org/codelist/user/alex-walker/glp1s-dmd/524886d2/
https://www.opencodelists.org/codelist/user/alex-walker/dpp-4-inhibitors-dmd/57ae06be/ https://www.opencodelists.org/codelist/user/alex-walker/metformin-dmd/258f2054/ https://www.opencodelists.org/codelist/user/alex-walker/pioglitazone-dmd/3bebd393/ https://www.opencodelists.org/codelist/user/alex-walker/sglt-2-inhibitors-dmd/2029a068/ https://www.opencodelists.org/codelist/user/alex-walker/sulfonylureas-dmd/6e0ab9fd/
Search Terms I am unsure.
Inclusion Criteria for Codes I am unsure.
Exclusion Criteria for Codes I am unsure.
Borderline Cases to Highlight NA
Codelist NA